146 completed, 21 unknown, 10 terminated, 5 active not recruiting. 56 Not applicable, 25 Phase 2, 14 Phase 4, 13 Phase 1, 13 Phase 3.
Follow HIV Seropositivity: new trials by email Literature Review of HIV Seropositivity trials Research Report on HIV Seropositivity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| This Study Evaluates the ALPCO Syphilis-T and Syphilis-NT CLIA Kits for Detecting Syphilis Antibodies in Serum and Plasma. Samples From At-risk, HIV-positive, Pregnant, and Healthy Individuals Will Assess Assay Performance Versus Established Comparator Tests. ALPCO Syphilis-T, ALPCO Syphilis-NT CLIA Kits - Treponema Pallidum, Treponema Pallidum Infection | Recruiting | American Laboratory Products Company | 1000 | 2025-12-10 | 2026-09-16 | |
| Study of the Prevalence of Transmitted HIV-1 Resistance, Viral Diversity, and Cluster Identification in Patients at the Time of HIV-1 Diagnosis HIV Seropositivity, HIV Drug Resistance | Not yet recruiting | ANRS, Emerging Infectious Diseases | 30060 | 2025-09-01 | 2025-08-28 | |
| Phase II Trial of BrECADD in HIV-Positive Patients With Advanced-Stage Classical Hodgkin Lymphoma BrECADD - Hodgkin Lymphoma (Category) | Phase 2 | Not yet recruiting | University of Cologne | 35 | 2025-08-01 | 2025-04-09 |
| Implementation and Effectiveness of a Psychosocial Intervention Among Registered People Living With HIV(HIV Patients) at Pakistan Institute of Medical Sciences (PIMS) Islamabad Pakistan. psychosocial - HIV Positive | Not applicable | Completed | Pakistan Institute of Medical Sciences | 128 | 2025-03-14 | 2025-07-02 |
| Immuno-virological Evaluation of Persons Living With HIV (PLWH) Leucapheresis - HIV-1-infection, HIV Seropositivity | Not applicable | Recruiting | University Hospital, Ghent | 24 | 2025-02-13 | 2026-09-21 |
| Clinical Trial of Gammora® Plus Antiretroviral Treatment for HIV Gammora® - HIV Seropositivity | Phase 2 | Active not recruiting | Federal University of São Paulo | 40 | 2025-01-01 | 2026-06-01 |
| Anti-CD 19 CAR-T Cell Therapy in Patients With ANCA Vasculitis KYV-101, an autologous fully-human anti-CD19 CAR T-cell immunotherapy - ANCA-IgG-positive ANCA Associated Vasculitis | Phase 1 / Phase 2 | Not yet recruiting | David Simon | 8 | 2025-01-01 | 2024-09-19 |
| A Multilevel, Multiphase Optimization Strategy for PrEP (MOST:PrEP) Computer-based simulation training for providers, Best Practice Alert, HIV Risk Assessment - HIV Seropositivity | Not applicable | Enrolling by invitation | Henry Ford Health System | 1380 | 2024-06-19 | 2026-09-21 |
| Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and Rifapentine With Pharmacokinetics of Dolutegravir (DTG) in Pregnant People With HIV Rifapentine, Isoniazid - HIV Seropositivity, Pregnancy | Phase 1 / Phase 2 | Active not recruiting | The Aurum Institute NPC | 252 | 2024-01-17 | 2025-12-12 |
| Bone, Inflammation, Gut and Renal Biomarkers in Antiretroviral Naïve HIV-1 Positive Subjects blood and urinary samples - HIV Positive | Not applicable | Withdrawn | Centre Hospitalier Universitaire de Saint Etienne | 2023-10-01 | 2023-11-22 | |
| The Evaluation of Anti-interference Ability and Clinical Specificity of HIV Ag +Ab Assay Kit (Sysmex) HIV Ag +Ab Assay Kit (Sysmex) - HIV Seropositivity, Cancer | Unknown | Qianfoshan Hospital | 1200 | 2023-09-20 | 2023-08-09 | |
| Lower Urinary Tract Symptoms in Males Living With HIV Questionnaires - HIV Seropositivity, Lower Urinary Tract Symptoms | Completed | Koç University | 55 | 2023-08-01 | 2024-04-17 | |
| Comparing Treatment Completion Of Daily Rifapentine & Isoniazid For One Month (1HP) To Weekly High Dose Rifapentine & Isoniazid For 3 Months (3HP) In Persons Living With HIV and in Household Contacts of Recently Diagnosed Tuberculosis Patients Daily rifapentine and isoniazid for 4 weeks, Weekly rifapentine and isoniazid for 12 weeks - HIV Seropositivity, Tuberculosis | Phase 4 | Active not recruiting | The Aurum Institute NPC | 1000 | 2023-07-19 | 2025-12-12 |
| The Value of HPV Testing for Cervical Cancer Screening in Women Living With HIV (PAPILLO-VIH) HIV Seropositivity | Unknown | Centre Hospitalier de Saint-Denis | 200 | 2023-07-01 | 2023-08-01 | |
| Telehealth Delivery (Tele-B6) Tele-B6, Delayed intervention (waitlist control) - HIV Seropositivity, Bisexuality | Not applicable | Completed | Emory University | 60 | 2023-04-18 | 2026-04-20 |
| Probiotics and Influenza Vaccination Response Probiotic effect on influenza vaccine response - Vaccine Response | Not applicable | Completed | The Archer-Daniels-Midland Company | 100 | 2023-03-20 | 2023-08-24 |
| Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support Intervention Social Network Support Intervention - HIV Seropositivity | Not applicable | Recruiting | University of Chicago | 900 | 2023-02-13 | 2026-04-08 |
| Feasibility of Positive Links for Youth Care Engagement Intervention Mobile health app - HIV Antibody Positivity | Not applicable | Completed | The University of Texas Health Science Center at San Antonio | 29 | 2023-02-02 | 2026-09-15 |
| ANTI-SARS-CoV-2 SEROCONVERSIO IN IMMUNE-MEDIATED KIDNEY DISEASES Immune-mediated Diseases, Glomerulonephritis | Completed | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 120 | 2022-09-09 | 2024-12-31 | |
| A Study to Evaluate AAV9 Neutralizing Antibody Seroconversion in Household Contacts. Blood Draw - Household Contacts | Terminated | Pfizer | 8 | 2022-08-17 | 2025-02-26 |
Showing 20 of 194. Sign in to see all of them.
HIV Infections (54) · Acquired Immunodeficiency Syndrome (30) · COVID-19 (9) · Diarrhea (5) · AIDS-Related Complex (4) · Hepatitis C (4) · Opioid-Related Disorders (4) · Poliomyelitis (4) · Sexually Transmitted Diseases (4) · Malaria (3) · Metabolic Syndrome (3) · Neoplasms (3) · Coitus (2) · Fever (2)
Blood-Borne Infections (194) · Communicable Diseases (194) · Genital Diseases (194) · Immune System Diseases (194) · Infections (194) · Lentivirus Infections (194) · RNA Virus Infections (194) · Retroviridae Infections (194) · Sexually Transmitted Diseases, Viral (194) · Urogenital Diseases (194) · Immunologic Deficiency Syndromes (193) · Virus Diseases (193) · Sexually Transmitted Diseases (190) · HIV Infections (140) · Slow Virus Diseases (32)
Blood Specimen Collection (5) · Lamivudine (5) · Raltegravir Potassium (5) · Tenofovir (5) · Emtricitabine (3) · Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (3) · Surveys and Questionnaires (3) · Zidovudine (3) · efavirenz (3) · fanasil, pyrimethamine drug combination (3) · poly(I).poly(c12,U) (3) · Counseling (2) · Isoniazid (2) · Lopinavir (2) · Ritonavir (2)
National Institute of Allergy and Infectious Diseases (NIAID) (16) · University of Washington (6) · ANRS, Emerging Infectious Diseases (5) · University of North Carolina, Chapel Hill (5) · Centers for Disease Control and Prevention (3) · Fondation Ophtalmologique Adolphe de Rothschild (3) · National Cancer Institute (NCI) (3) · University Hospital, Ghent (3) · University of California, San Diego (3) · Wayne State University (3) · AIM ImmunoTech Inc. (2) · Aga Khan University (2) · Centre Hospitalier Universitaire de Nice (2) · Centre for Infectious Disease Research in Zambia (2) · Columbia University (2)
United States (83) · France (22) · South Africa (9) · Zambia (6) · Brazil (4) · Italy (4) · Kenya (4) · Uganda (4) · Belgium (3) · India (3) · Mali (3) · Mozambique (3) · Pakistan (3) · Puerto Rico (3) · Zimbabwe (3)
David R Strayer, MD (2) · Mark Greenwald, PhD (2) · Abdel K Traore, MD (1) · Adrian S Dobs, M.D. (1) · Ahna Pai, Ph.D (1) · Alan Winston, MD (1) · Ali F Saleem, MBBS, MCR, FCPS (1) · Alida Bouris, PhD (1) · Alison M Morris, MD, MS (1) · Alwine Kardinaal, PhD (1) · Alwyn Mwinga, PhD (1)
PMID 39324693, PMID 21436711, PMID 32779730, PMID 39101506, PMID 10843271, PMID 12631091, PMID 14527974, PMID 14656623, PMID 15020559, PMID 1594721, PMID 16800167, PMID 18008241, PMID 18193495, PMID 18528326, PMID 19008157, PMID 19059048, PMID 19538732, PMID 19719796, PMID 20513828, PMID 20843990, PMID 20949113, PMID 2161532, PMID 21859691, PMID 22592096, PMID 22784037, PMID 22820612, PMID 22842844, PMID 23021515, PMID 23085245, PMID 23388678, PMID 23482645, PMID 23615312, PMID 23939368, PMID 24386229, PMID 24979446, PMID 25038355, PMID 25300863, PMID 25393648, PMID 25531343, PMID 26666313, PMID 26852237, PMID 27015639, PMID 27029778, PMID 27085172, PMID 27465646, PMID 28301423, PMID 28658251, PMID 28736139, PMID 28828217, PMID 28857822
2017 (2), R01DA032678 (2), 2018 (1), 2025 (1), 5UM1AI068633 (1), D43TW009345 (1), K23MH108440 (1), P30AI064518 (1), P30AI094189 (1), R00HD076679 (1), R01AI099601 (1), R01AI114320 (1), R01DA017612 (1), R01DA047789 (1), R01DA050486 (1)